News

Associate professor Jia Ruan, M.D., Ph.D., talks to OncLive about initial treatment methods for mantle cell lymphoma (MCL). Read more

Richard Furman, M.D., director of Weill's CLL Research Center, participates in a panel discussion about therapy for patients with chronic lymphocytic leukemia (CLL) whose tumors harbor a 17p deletion. Read more

Manish A Shah, M.D., director of gastrointestinal oncology, discusses a recent phase II study of FOLFOX with or without onartuzumab, a MET inhibitor, for the treatment of metastatic gastroesophageal adenocarcinoma. Read more

Image-guided radiotherapy (IGRT) delivers highly accurate doses of radiation therapy to targeted areas in the brain while maximizing patient comfort in a procedure called stereotactic radiosurgery. Read more

Irene Price is an early beneficiary of “precision medicine,” an approach that replaces the traditional one-size-fits-all cancer treatment paradigm with one that focuses on targeted, individualized care using a patient’s own genetic profile and medical history. Read more

Richard Furman, director of Weill’s Chronic Lymphocytic Leukemia Research Center, weighs in on debates about when and how to treat patients with CLL. Read more

Cancer: It’s personal, and not only on an emotional level, but a molecular one. Every patient's cancer is unique, driven by distinct biological factors. So, too, should every patient’s treatment. Read more

A new database that maps how cells regulate gene expression could provide strategies to stop tumor growth. Read more

Gail Roboz, director of the Leukemia Program, presented an educational platform discussing the introduction of epigenetic and personalized therapies targeting AML at the ASH Annual Meeting. Read more